Dr. Prasad received his MD degree from Institute of Medical Sciences, Varanasi, India. He completed his neurology residency at New York University Medical Center, New York. He then pursued Epilepsy fellowships of 1 year at New York University Medical Center and 2 years at University of Virginia Medical Center. He worked as Assistant professor at University of Alabama, Birmingham for 3 years before joining Hartford Hospital.
Dr. Prasad is board certified by the American Board of Psychiatry and Neurology and American Board of Clinical Neurophysiology.
1. Extent of ictal origin in mesial temporal sclerosis patients monitored with subduralintracranial electrodes predicts outcome. A Prasad, SV Pacia, O Devinsky, WK Doyle. J of Clinical Neurophysiology. 20;243-248:2003.
2. Evolving Antiepileptic drug therapy in juvenile myoclonic epilepsy. A Prasad, R Martin, R Knowlton, M Mendez, T Welty, R Kuzniecky, E Faught. Archives of Neurology. 60;1100-1105:2003. 3. Neurotoxicity following addition of intravenous valproate to lamotrigine therapy. A Prasad, R Martin, R Knowlton, R Mendez, T Welty, R Kuzniecky, E Faught. Neurology.60;1991-1992:2003.
4. Teddy bears: an interesting observational finding in patients with nonepileptic events. J Burneo, R Martin, R Knowlton, M Mendez, E Faught, A Prasad, R Kuzniecky. Neurology. 61;714-715:2003.
5. Phenobarbital and MK-801, but not phenytoin, improve long-term outcome in status epilepticus. A Prasad, Williamson J, EH Bertram. Annals of Neurology. 52;175-181:2001.
6. Propofol and midazolam in the treatment of refractory status epilepticus. A Prasad, B Worrall, EH Bertram, T P Bleck. Epilepsia 42;380- 386:2001.
To request a referral or to make an appointment, call the Physician Referral Line.
For questions regarding the information shown on this page, contact our Physician Liaison.